By using propensity score matching (PSM) to reduce selection bias and conducting stratified analysis on key prognostic factors including AFP level, tumor diameter, tumor number, MVI and PVTT, we aim to clarify the efficacy of adjuvant therapy in different high-risk recurrence risk subgroups. The gene discussed is AFP; the disease is neoplasm.